Literature DB >> 30302789

Investigation of structural stability and functionality of homodimeric gramicidin towards peptide-based drug: a molecular simulation approach.

Pavithrra Ganesan1, Rajasekaran Ramalingam1.   

Abstract

Increasing death rates due to antibiotic resistance deteriorate the existing treatment measures. Antimicrobial peptides have turned into the emerging cure for multidrug resistance. However, the stability and functionality determine an antimicrobial peptide as a drug. Analyses of the homodimeric β-helical peptide, gramicidin have suggested the significant role of gramicidin-A, gramicidin-B, and gramicidin-C as antimicrobial compounds, but the structural basis for understanding the stability and functionality is insufficient to resolve multidrug resistance. To identify the best template among gramicidin types as a therapeutic product, we combined a detailed comparative static analysis and dynamic analysis along with conformational free energy and secondary structure prediction. We observed that the high intramolecular interactions and the geometrical features favored gramicidin-A among other types of gramicidin. Our analyses further revealed that the secondary structure of gramicidin-A showed β sheets with coils along the conformations without any disruption, thereby enhanced its membrane interactions in terms of binding free energy. In conclusion, gramicidin-A has definitely showed enhanced structural stability and functionality; this could be considered the best template for a potential therapeutic product.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  antimicrobial peptides; drug resistance; gramicidin (g-A, g-B, and g-C); stability and functionality

Mesh:

Substances:

Year:  2018        PMID: 30302789     DOI: 10.1002/jcb.27765

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.

Authors:  Muhammad Tahir Khan; Abbas Khan; Ashfaq Ur Rehman; Yanjie Wang; Khalid Akhtar; Shaukat Iqbal Malik; Dong-Qing Wei
Journal:  Sci Rep       Date:  2019-05-16       Impact factor: 4.379

2.  Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance.

Authors:  Aamir Mehmood; Muhammad Tahir Khan; Aman Chandra Kaushik; Anwar Sheed Khan; Muhammad Irfan; Dong-Qing Wei
Journal:  Front Bioeng Biotechnol       Date:  2019-12-10

3.  Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance.

Authors:  Muhammad Tahir Khan; Sajid Ali; Muhammad Tariq Zeb; Aman Chandra Kaushik; Shaukat Iqbal Malik; Dong-Qing Wei
Journal:  Front Mol Biosci       Date:  2020-04-09

4.  Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell-Mediated Tumor Therapy.

Authors:  Yilei Chen; Hongxing Huang; Yin Liu; Zhanghao Wang; Lili Wang; Quanxiao Wang; Yan Zhang; Hua Wang
Journal:  Cancer Res Treat       Date:  2021-08-03       Impact factor: 4.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.